U.S., Nov. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07251712) titled 'Single and Multiple Dose Pharmacokinetics (PK) of Aramchol From an Aramchol Meglumine Tablet' on Nov. 14.
Brief Summary: Evaluate the exposure of of Aramchol from 2 different single doses of Aramchol meglumine tablet and to compare the exposure of steady state from a selected dose of Aramchol meglumine tablet.
Study Start Date: Dec. 25
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: Aramchol
Aramchol tablet at 2 different single doses
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Galmed Pharmaceuticals Ltd
Disclaimer: Curated by HT Syndication....